A case of belatacept-induced chilblain lupus

Neha Kinariwalla; Meera Tarazi; Jesse M Lewin; Sameera Husain; Syed A Husain; Stephanie M Gallitano

doi:10.1016/j.jdcr.2022.01.007

A case of belatacept-induced chilblain lupus

JAAD Case Rep. 2022 Jan 22:21:112-115. doi: 10.1016/j.jdcr.2022.01.007. eCollection 2022 Mar.

Authors

Neha Kinariwalla¹, Meera Tarazi², Jesse M Lewin³, Sameera Husain², Syed A Husain⁴, Stephanie M Gallitano²

Affiliations

¹ Columbia University Vagelos College of Physicians and Surgeons, New York, New York.
² Department of Dermatology, Columbia University Vagelos College of Physicians and Surgeons, New York, New York.
³ The Kimberly and Eric J. Waldman Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York.
⁴ Department of Medicine, Division of Nephrology, Columbia University Vagelos College of Physicians and Surgeons, New York, New York.

No abstract available

Keywords: CHLE, chilblain lupus erythematosus; CTLA-4, cytotoxic T-lymphocyte–associated antigen 4; SCLE, subacute cutaneous lupus erythematosus; belatacept; chilblains systemic lupus erythematous; immunosuppression; kidney transplant.

Publication types

Case Reports